Cargando…
Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology
BACKGROUND: Gastric cancer was still one of the commonly diagnosed cancer types and the third-most common cause of cancer-related death in the world. Gentiopicroside, which is extracted from the Gentianella acuta, is commonly used in both traditional treatment and modern clinical care; therefore, it...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700081/ https://www.ncbi.nlm.nih.gov/pubmed/33262572 http://dx.doi.org/10.2147/DDDT.S270757 |
_version_ | 1783616195458498560 |
---|---|
author | Huang, Yanxia Lin, Jiatong Yi, Weimin Liu, Qinghua Cao, Linhui Yan, Yongcong Fu, Anqi Huang, Tingxuan Lyu, Yingcheng Huang, Qihui Wang, Jie |
author_facet | Huang, Yanxia Lin, Jiatong Yi, Weimin Liu, Qinghua Cao, Linhui Yan, Yongcong Fu, Anqi Huang, Tingxuan Lyu, Yingcheng Huang, Qihui Wang, Jie |
author_sort | Huang, Yanxia |
collection | PubMed |
description | BACKGROUND: Gastric cancer was still one of the commonly diagnosed cancer types and the third-most common cause of cancer-related death in the world. Gentiopicroside, which is extracted from the Gentianella acuta, is commonly used in both traditional treatment and modern clinical care; therefore, its anticancer effects have been attracted more attention. However, the systematic analysis of action mechanism of Gentiopicroside on gastric cancer (GC) has not yet been carried out. AIM: A network pharmacology-based strategy combined with molecular docking studies and in vitro validation was employed to investigate potential targets and molecular mechanism of Gentiopicroside against GC. MATERIALS AND METHODS: Potential targets of Gentiopicroside, as well as related genes of GC, were acquired from public databases. Potential targets, and signaling pathways were determined through bioinformatic analysis, including protein–protein interaction (PPI), the Gene Ontology (GO), and the Kyoto Encyclopedia of Genes and Genomes (KEGG). Subsequently, molecular docking and cell experiments were performed to further verify the above findings. RESULTS: Our findings revealed that the anticancer activity of Gentiopicroside potentially involves 53 putative identified target genes. In addition, GO, KEGG, and network analyses revealed that these targets were associated with cell proliferation, metabolic process, and other physiological processes. Furthermore, we have proved that critical compound affected the expression of CCND1, CCNE1, p-AKT and p-P38 at protein levels. These findings provide an overview of the anticancer action of Gentiopicroside from a network perspective; meanwhile, it might also set an example for future studies of other materials used in traditional Chinese medicine (TCM). CONCLUSION: This study comprehensively illuminated the potential targets and molecular mechanism of Gentiopicroside against GC. It also provided a promising approach to uncover the scientific basis and therapeutic mechanism of TCM treating for disease. |
format | Online Article Text |
id | pubmed-7700081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-77000812020-11-30 Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology Huang, Yanxia Lin, Jiatong Yi, Weimin Liu, Qinghua Cao, Linhui Yan, Yongcong Fu, Anqi Huang, Tingxuan Lyu, Yingcheng Huang, Qihui Wang, Jie Drug Des Devel Ther Original Research BACKGROUND: Gastric cancer was still one of the commonly diagnosed cancer types and the third-most common cause of cancer-related death in the world. Gentiopicroside, which is extracted from the Gentianella acuta, is commonly used in both traditional treatment and modern clinical care; therefore, its anticancer effects have been attracted more attention. However, the systematic analysis of action mechanism of Gentiopicroside on gastric cancer (GC) has not yet been carried out. AIM: A network pharmacology-based strategy combined with molecular docking studies and in vitro validation was employed to investigate potential targets and molecular mechanism of Gentiopicroside against GC. MATERIALS AND METHODS: Potential targets of Gentiopicroside, as well as related genes of GC, were acquired from public databases. Potential targets, and signaling pathways were determined through bioinformatic analysis, including protein–protein interaction (PPI), the Gene Ontology (GO), and the Kyoto Encyclopedia of Genes and Genomes (KEGG). Subsequently, molecular docking and cell experiments were performed to further verify the above findings. RESULTS: Our findings revealed that the anticancer activity of Gentiopicroside potentially involves 53 putative identified target genes. In addition, GO, KEGG, and network analyses revealed that these targets were associated with cell proliferation, metabolic process, and other physiological processes. Furthermore, we have proved that critical compound affected the expression of CCND1, CCNE1, p-AKT and p-P38 at protein levels. These findings provide an overview of the anticancer action of Gentiopicroside from a network perspective; meanwhile, it might also set an example for future studies of other materials used in traditional Chinese medicine (TCM). CONCLUSION: This study comprehensively illuminated the potential targets and molecular mechanism of Gentiopicroside against GC. It also provided a promising approach to uncover the scientific basis and therapeutic mechanism of TCM treating for disease. Dove 2020-11-23 /pmc/articles/PMC7700081/ /pubmed/33262572 http://dx.doi.org/10.2147/DDDT.S270757 Text en © 2020 Huang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Huang, Yanxia Lin, Jiatong Yi, Weimin Liu, Qinghua Cao, Linhui Yan, Yongcong Fu, Anqi Huang, Tingxuan Lyu, Yingcheng Huang, Qihui Wang, Jie Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology |
title | Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology |
title_full | Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology |
title_fullStr | Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology |
title_full_unstemmed | Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology |
title_short | Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology |
title_sort | research on the potential mechanism of gentiopicroside against gastric cancer based on network pharmacology |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700081/ https://www.ncbi.nlm.nih.gov/pubmed/33262572 http://dx.doi.org/10.2147/DDDT.S270757 |
work_keys_str_mv | AT huangyanxia researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology AT linjiatong researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology AT yiweimin researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology AT liuqinghua researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology AT caolinhui researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology AT yanyongcong researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology AT fuanqi researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology AT huangtingxuan researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology AT lyuyingcheng researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology AT huangqihui researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology AT wangjie researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology |